Renovaro Biosciences
RENB
#8802
Rank
HK$0.75 B
Marketcap
HK$4.68
Share price
-4.43%
Change (1 day)
-80.84%
Change (1 year)

EPS for Renovaro Biosciences (RENB)

EPS in 2023 (TTM): -HK$15.85

According to Renovaro Biosciences's latest financial reports the company's current EPS (TTM) is -HK$15.72. In 2022 the company made an earnings per share (EPS) of -HK$16.03 a decrease over its 2021 EPS that were of -HK$6.15.

EPS history for Renovaro Biosciences from 2012 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$15.85-1.13%
2022-HK$16.03160.76%
2021-HK$6.15243.48%
2020-HK$1.7943.75%
2019-HK$1.24-74.87%
2018-HK$4.95339.47%
2017-HK$1.13-48.26%
2016-HK$2.18-22.22%
2015-HK$2.807.39%
2014-HK$2.614351.27%
2013-HK$0.0586016.6%
2012-HK$0.05026